https://globalinfectiousdisease.com/research/ Published infectious-disease literature filtered to Switzerland. en Wed, 09 Sep 2026 07:02:01 GMT https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-75380-3-7f712cd2/ https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-75380-3-7f712cd2/ Sat, 11 Jul 2026 00:00:00 GMT Environmental monitoring programs could utilize this analytical approach to maintain continuous epidemiological tracking in areas where traditional clinical reporting is incomplete or resource-constrained. SARS COVID-19 Influenza Surveillance Transmission dynamics Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-18-2300558-9973be5c/ https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-18-2300558-9973be5c/ Thu, 02 May 2024 00:00:00 GMT The findings support vaccination recommendations by demonstrating that even young children can experience severe TBE and that complete vaccination provides durable protection against neurological disease for at least 10 years. Tick-borne encephalitis Surveillance Vaccination Vaccine effectiveness Case-control study https://globalinfectiousdisease.com/research/articles/10-1016-j-epidem-2022-100654-cba6ac2b/ https://globalinfectiousdisease.com/research/articles/10-1016-j-epidem-2022-100654-cba6ac2b/ Thu, 01 Dec 2022 00:00:00 GMT The findings indicate that cross-border-associated cases were an important component of the modeled Swiss epidemic dynamics during the studied summer periods. The abstract states that understanding this contribution may inform future surveillance strategies. SARS COVID-19 Travel medicine Outbreak investigation Surveillance Transmission dynamics Journal article https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2022-27-10-2100806-b30168de/ https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2022-27-10-2100806-b30168de/ Thu, 10 Mar 2022 00:00:00 GMT The findings support the potential use of targeted digital PCR in wastewater to monitor variant frequency and may indicate changes earlier than clinical sequencing. The evidence presented is specific to the reported Zurich analysis and does not establish performance in other settings. COVID-19 SARS Surveillance Transmission dynamics Vaccination Genomic epidemiology Genomic study https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-15-00486-7-1b1ae76c/ https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-15-00486-7-1b1ae76c/ Tue, 01 Mar 2016 00:00:00 GMT The paper is relevant to Ebola vaccine development because it provides early human safety and immune-response data for a candidate vaccine during an outbreak context. It is positioned as evidence to support later-phase efficacy studies rather than as a population-level effectiveness assessment. Ebola Hemorrhagic Fever Treatment Vaccination Outbreak investigation Randomised controlled trial